Fresenius Gets PTAB To Deal Another Blow On Cubicin Patents
Cubist Pharmaceuticals was dealt another setback in its ongoing fight to preserve patents on its blockbuster antibiotic Cubicin as the Patent Trial and Appeal Board ruled Thursday that various claims in...To view the full article, register now.
Already a subscriber? Click here to view full article